UroGen Pharma Ltd Logo

UroGen Pharma Ltd (URGN): Eigentümerstruktur

Takani Score ?
38.4

Preis (29.10.2026)52W Hoch52W Tief
33,48 US Dollar50,81 US Dollar16,5 US Dollar
Analysten KonsensBuy Outperform Hold Underperform Sell
60 US Dollar6 1 1 0 0
Externe Analystenschätzungen (Quelle: EODHD). Keine Anlageberatung, keine Anlageempfehlung von Takani.
#SharesShort [%] Short Ratio
48.880.56411,7 5,87

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name UroGen Pharma Ltd
Mitarbeiter 300
Handelsplatz NASDAQ
Ticker Symbol URGN
IPO Datum 2017-05-04
Adresse 400 Alexander Park Drive, Princeton, NJ, United States, 08540

Unternehmensführung

RangNamePosition
1Ms. Elizabeth A. BarrettPresident, CEO & Director
2Mr. Jason Drew Smith J.D.General Counsel, Chief Compliance Officer & Corporate Secretary
3Dr. Mark P. Schoenberg M.D.Chief Medical Officer
4Mr. Christopher Degnan CPAChief Financial Officer
5Mr. Vincent I. PerroneSenior Director of Investor Relations
6Ms. Alison HardgroveSenior Vice President of Human Resources
7Dr. Marina Konorty Ph.D.Executive Vice President of Research & Development and Technical Operations
8Mr. James Ottinger R.ph.Executive Vice President of Regulatory Affairs & Quality
9Mr. Michael J. Louie M.D., M.P.H., M.Sc.Chief Development Officer
10Mr. Timothy SimonSenior Vice President of Business Development & Portfolio Strategy

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1RTW INVESTMENTS, LLC9,30%0,15 Mrd. USD
2BlackRock Inc6,55%0,11 Mrd. USD
3Morgan Stanley - Brokerage Accounts5,27%0,09 Mrd. USD
4Kynam Capital Management, LP4,98%0,08 Mrd. USD
5Jefferies Financial Group Inc4,50%0,07 Mrd. USD
6SG Americas Securities, LLC4,20%0,07 Mrd. USD
7American Century Companies Inc3,45%0,06 Mrd. USD
8Point72 Asset Management, L.P.3,12%0,05 Mrd. USD
9Frontier Capital Management CO Inc3,09%0,05 Mrd. USD
10Opaleye Management Inc2,95%0,05 Mrd. USD
11SILVERARC CAPITAL MANAGEMENT, LLC2,66%0,04 Mrd. USD
12MENORA MIVTACHIM HOLDINGS LIMITED2,36%0,04 Mrd. USD
13D. E. Shaw & Co LP2,34%0,04 Mrd. USD
14State Street Corp2,05%0,03 Mrd. USD
15MPM Oncology Impact Management LP1,91%0,03 Mrd. USD
16Soleus Capital Management, L.P.1,70%0,03 Mrd. USD
17The Goldman Sachs Group Inc1,68%0,03 Mrd. USD
18Migdal Insurance & Financial Holdings Ltd1,58%0,03 Mrd. USD
19Orbimed Advisors LLC1,38%0,02 Mrd. USD
20Geode Capital Management, LLC1,25%0,02 Mrd. USD